Tolerability of statin-based management of patients with a history of statin-associated muscle symptoms: protocol for a systematic review

Introduction Statin-associated muscle symptoms (SAMSs) are a major clinical issue in the primary and secondary prevention of cardiovascular events. Current guidelines advise various approaches mainly based on expert opinion. We will lead a systematic review and meta-analysis to explore the tolerabil...

Full description

Bibliographic Details
Main Authors: Manuel R Blum, Nicolas Rodondi, Cinzia Del Giovane, Fanny Villoz, Christina Lyko
Format: Article
Language:English
Published: BMJ Publishing Group 2021-08-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/8/e052341.full
_version_ 1819150756866949120
author Manuel R Blum
Nicolas Rodondi
Cinzia Del Giovane
Fanny Villoz
Christina Lyko
author_facet Manuel R Blum
Nicolas Rodondi
Cinzia Del Giovane
Fanny Villoz
Christina Lyko
author_sort Manuel R Blum
collection DOAJ
description Introduction Statin-associated muscle symptoms (SAMSs) are a major clinical issue in the primary and secondary prevention of cardiovascular events. Current guidelines advise various approaches mainly based on expert opinion. We will lead a systematic review and meta-analysis to explore the tolerability and acceptability and effectiveness of statin-based therapy management of patients with a history of SAMS. We aim to provide evidence on the tolerability and different strategies of statin-based management of patients with a history of SAMS.Methods and analysis We will conduct a systematic review of randomised controlled trials (RCTs) and non-randomised studies with a control group. We will search in Data sources MEDLINE, EMBASE, Cochrane Central Register of Controlled Clinical Trials, Scopus, Clinicaltrials.gov and Proquest from inception until April 2021. Two independent reviewers will carry out the study selection based on eligibility criteria. We will extract data following a standard data collection form. The reviewers will use the Cochrane Collaboration’s tools and Newcastle-Ottawa Scale to appraise the study risk of bias. Our primary outcome will be tolerability and our secondary outcomes will be acceptability and effectiveness. We will conduct a qualitative analysis of all included studies. In addition, if sufficient and homogeneous data are available, we will conduct quantitative analysis. We will synthesise dichotomous data using OR with 95% CI and continuous outcomes by using mean difference or standardised mean difference (with 95% CI). We will determine heterogeneity visually with forest plots and quantitatively with I2 and Q-test. We will summarise the confidence in the quantitative estimate by using Grading of Recommendations Assessment, Development and Evaluation approach.Ethics and dissemination As a systematic review of literature without collection of new clinical data, there will be no requirement for ethical approval. We will disseminate findings through peer-reviewed publications.PROSPERO registration number CRD42020202619.
first_indexed 2024-12-22T14:22:34Z
format Article
id doaj.art-7a1543b3ddb1451c8306db1e5c618b27
institution Directory Open Access Journal
issn 2044-6055
language English
last_indexed 2024-12-22T14:22:34Z
publishDate 2021-08-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj.art-7a1543b3ddb1451c8306db1e5c618b272022-12-21T18:22:57ZengBMJ Publishing GroupBMJ Open2044-60552021-08-0111810.1136/bmjopen-2021-052341Tolerability of statin-based management of patients with a history of statin-associated muscle symptoms: protocol for a systematic reviewManuel R Blum0Nicolas Rodondi1Cinzia Del Giovane2Fanny Villoz3Christina Lyko4Institute of Primary Health Care (BIHAM), University of Bern, Bern, SwitzerlandInstitute of Primary Health Care (BIHAM), University of Bern, Bern, SwitzerlandInstitute of Primary Health Care (BIHAM), University of Bern, Bern, SwitzerlandInstitute of Primary Health Care (BIHAM), University of Bern, Bern, SwitzerlandInstitute of Primary Health Care (BIHAM), University of Bern, Bern, SwitzerlandIntroduction Statin-associated muscle symptoms (SAMSs) are a major clinical issue in the primary and secondary prevention of cardiovascular events. Current guidelines advise various approaches mainly based on expert opinion. We will lead a systematic review and meta-analysis to explore the tolerability and acceptability and effectiveness of statin-based therapy management of patients with a history of SAMS. We aim to provide evidence on the tolerability and different strategies of statin-based management of patients with a history of SAMS.Methods and analysis We will conduct a systematic review of randomised controlled trials (RCTs) and non-randomised studies with a control group. We will search in Data sources MEDLINE, EMBASE, Cochrane Central Register of Controlled Clinical Trials, Scopus, Clinicaltrials.gov and Proquest from inception until April 2021. Two independent reviewers will carry out the study selection based on eligibility criteria. We will extract data following a standard data collection form. The reviewers will use the Cochrane Collaboration’s tools and Newcastle-Ottawa Scale to appraise the study risk of bias. Our primary outcome will be tolerability and our secondary outcomes will be acceptability and effectiveness. We will conduct a qualitative analysis of all included studies. In addition, if sufficient and homogeneous data are available, we will conduct quantitative analysis. We will synthesise dichotomous data using OR with 95% CI and continuous outcomes by using mean difference or standardised mean difference (with 95% CI). We will determine heterogeneity visually with forest plots and quantitatively with I2 and Q-test. We will summarise the confidence in the quantitative estimate by using Grading of Recommendations Assessment, Development and Evaluation approach.Ethics and dissemination As a systematic review of literature without collection of new clinical data, there will be no requirement for ethical approval. We will disseminate findings through peer-reviewed publications.PROSPERO registration number CRD42020202619.https://bmjopen.bmj.com/content/11/8/e052341.full
spellingShingle Manuel R Blum
Nicolas Rodondi
Cinzia Del Giovane
Fanny Villoz
Christina Lyko
Tolerability of statin-based management of patients with a history of statin-associated muscle symptoms: protocol for a systematic review
BMJ Open
title Tolerability of statin-based management of patients with a history of statin-associated muscle symptoms: protocol for a systematic review
title_full Tolerability of statin-based management of patients with a history of statin-associated muscle symptoms: protocol for a systematic review
title_fullStr Tolerability of statin-based management of patients with a history of statin-associated muscle symptoms: protocol for a systematic review
title_full_unstemmed Tolerability of statin-based management of patients with a history of statin-associated muscle symptoms: protocol for a systematic review
title_short Tolerability of statin-based management of patients with a history of statin-associated muscle symptoms: protocol for a systematic review
title_sort tolerability of statin based management of patients with a history of statin associated muscle symptoms protocol for a systematic review
url https://bmjopen.bmj.com/content/11/8/e052341.full
work_keys_str_mv AT manuelrblum tolerabilityofstatinbasedmanagementofpatientswithahistoryofstatinassociatedmusclesymptomsprotocolforasystematicreview
AT nicolasrodondi tolerabilityofstatinbasedmanagementofpatientswithahistoryofstatinassociatedmusclesymptomsprotocolforasystematicreview
AT cinziadelgiovane tolerabilityofstatinbasedmanagementofpatientswithahistoryofstatinassociatedmusclesymptomsprotocolforasystematicreview
AT fannyvilloz tolerabilityofstatinbasedmanagementofpatientswithahistoryofstatinassociatedmusclesymptomsprotocolforasystematicreview
AT christinalyko tolerabilityofstatinbasedmanagementofpatientswithahistoryofstatinassociatedmusclesymptomsprotocolforasystematicreview